Skip to main content
Sinopharm Group Co. Ltd. logo

Sinopharm Group Co. Ltd. — Investor Relations & Filings

Ticker · 1099 ISIN · CNE100000FN7 LEI · 529900N54X78YH9JYK92 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,610 across all filing types
Latest filing 2024-11-06 Regulatory Filings
Country CN China
Listing HKEX 1099

About Sinopharm Group Co. Ltd.

http://www.sinopharmholding.com

Sinopharm Group Co. Ltd. is a major state-owned enterprise recognized as the largest pharmaceutical logistics provider in Asia and a leading distributor and retailer of healthcare products. The company's core business revolves around providing comprehensive medical supply chain services, encompassing the wholesale and retail distribution of pharmaceuticals, medical devices, and general healthcare products. Sinopharm serves a broad customer base, including hospitals, primary health service institutions, and retail pharmacies. Furthermore, the Group maintains an integrated ecosystem that extends beyond distribution into the manufacturing of pharmaceuticals and chemical reagents, medical services, and industry-finance integration, positioning it as a full-spectrum service provider in the healthcare sector.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 October 2024. It details movements in authorised/registered share capital, issued shares, treasury shares, and confirms no changes in share options, warrants, convertibles, or other arrangements. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting monthly share capital and shareholding movements. It is not a full financial report, earnings release, or management discussion. It is a regulatory filing reporting share capital and share movements as required by exchange rules. The document length is about 5900 characters, and it contains detailed share capital movement data but no financial statements or management commentary. Therefore, it fits best under Regulatory Filings (RNS) as a general compliance and reporting document that does not fit other specific categories like Share Issue/Capital Change (SHA) because it is a routine monthly return rather than a specific capital change announcement.
2024-11-06 English
ANNOUNCEMENT PRINCIPAL UNAUDITED ACCOUNTING DATA AND FINANCIAL INDICATORS OF SINOPHARM ACCORD FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2024
Regulatory Filings Classification · 95% confidence The document is an announcement of principal unaudited accounting data and financial indicators for the nine months ended 30 September 2024. It references a quarterly report of a subsidiary and provides summarized financial data such as revenue, net profit, earnings per share, and total assets. The document is relatively short (4282 characters) and is titled as an announcement rather than a full report. It does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR). Instead, it serves as a regulatory announcement of financial data pursuant to listing rules. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2024-10-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2024-10-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2024-10-28 English
ANNOUNCEMENT QUARTERLY FINANCIAL INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2024
Interim / Quarterly Report Classification · 95% confidence The document is an announcement containing detailed unaudited quarterly financial information for the nine months ended 30 September 2024. It includes consolidated balance sheets, income statements, and cash flow statements prepared according to PRC GAAP. The text references regulatory requirements for quarterly financial disclosures and provides comprehensive financial data for the period, not just highlights or a brief summary. The length of the document (15,000 characters) and the presence of substantive financial statements confirm it is a full interim/quarterly report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2024
2024-10-28 English
ANNOUNCEMENT PRINCIPAL UNAUDITED FINANCIAL DATA OF CNMDC FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2024
Interim / Quarterly Report Classification · 95% confidence The document is an announcement containing principal unaudited financial data for the nine months ended 30 September 2024 for a subsidiary company. It references the reporting period and provides key financial figures such as revenue, operating profit, and total assets. The document is relatively short (3352 characters) and is titled as an announcement rather than a full interim or quarterly report. It does not contain detailed financial statements or comprehensive analysis but rather summarizes key financial data. According to the rules, such a document that provides principal unaudited financial data in an announcement format is best classified as an Interim / Quarterly Report (IR) because it contains substantive financial data for a period shorter than a full fiscal year. The document is not merely a report publication announcement or a regulatory filing, as it includes actual financial data. Therefore, the appropriate classification is IR with high confidence. 9M 2024
2024-10-24 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.